Skip to content

Comparing the effect of Orthokin and Persica mouthrinses on periodontal condition in fixed orthodontic patients treated in privet office in year 1395

Effects of Fixed Orthodontic Treatment and Two Mouthrinses on Gingival Health: A Single blind placebo controlled clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016033024573N2
Enrollment
54
Registered
2016-06-06
Start date
2016-04-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of fix orthodontic treatment and two mouthrinses on periodontal condition..

Interventions

Intervention 1: Intervention: drug (mouth rinse) should be applied twice a day (preferably after each meal), as doses of 15 mL used for 30 seconds. Patients should avoid eating or drinking for about 3
Treatment - Drugs
Intervention: drug (mouth rinse) should be applied twice a day (preferably after each meal), as doses of 15 mL used for 30 seconds. Patients should avoid eating or drinking for about 30 minutes after
Control: placebo solution containing 35 cc glycerine, 35 cc distilled water, and 0.3 cc ethylene blue per 100 cc.

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion: Patients should be under fixed double jaw orthodontic treatment; Patients should not have usage of antibiotic and mouth-rinsing experience; Patients should not have numerous severe dental caries and/or restorations; Patients should not have severe dental plaque/ severe Gingival inflammation; Patients should not have periodontal surgery or periodontal disease experience; Patients should not have systemic disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Plaque index. Timepoint: Before bonding, 3 month after treatment start, 1 month after mouthrinse nad placebo. Method of measurement: Observation scoring by disclosing agent.

Secondary

MeasureTime frame
Gingival bleeding index. Timepoint: 3 month after treatment. Method of measurement: Visual scale by probing.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Sobouti

Department of Orthodontics, Dental Faculty of Sari, Mazandaran University of Medical Sciences.

farhad_sobouti@yahoo.com; farhad.sobouti@gmail.com+98 11 3332 1254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026